HomeIndustriesFood & BeveragePEP Earnings 'Less Bad Than Expected,' 'Ozempic Effect' Cuts Into Profits

PEP Earnings 'Less Bad Than Expected,' 'Ozempic Effect' Cuts Into Profits

PepsiCo (PEP) rallied on today's earnings, with Alexis Browne Roberts noting a "surprisingly resilient" consumer lifting the numbers. However, she still wouldn't buy the stock even after today's report, giving the case that today's earnings were only "less bad" than it could have been. Dale Smothers still sees the stock as a strong dividend play. One bearish take he gives is America's Ozempic Effect" that will hit PepsiCo's snack profits.

Trading 360

17 Jul 2025

SHARE

ON AIR
12:00 pm
Next Gen Investing
education
12:00 am
Your First Trade
REPLAY
education
12:30 am
Your First Trade
REPLAY
1:00 am
The Wrap
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Market Overtime
REPLAY
4:00 am
Market Overtime
REPLAY
education
4:30 am
Inside the Mind of a Trader
REPLAY
education
5:00 am
Inside the Mind of a Trader
REPLAY
education
5:30 am
Inside the Mind of a Trader
REPLAY
6:00 am
The Wrap
REPLAY
7:00 am
Morning Movers
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
ON AIR
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
7:00 pm
Market Overtime
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
The Wrap
REPLAY
9:00 pm
Market Overtime
REPLAY
9:30 pm
Market Overtime
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY

Schwab Network's Newsletters

Daily insights for every investor